African American Dialysis Patients Usually Live Longer Than Whites

by Savitha C Muppala on December 8, 2011 at 10:45 PM

A recent study has pointed out that African American dialysis patients usually live longer than whites.

High levels of inflammation—which may be due to conditions such as infections, inflammatory illnesses, periodontal disease, chronic lung disease, and obesity—increase dialysis patients' risk of dying prematurely. Deidra Crews, MD (Johns Hopkins University) and her colleagues wondered whether racial differences in inflammation might explain the survival paradox among dialysis patients.

Dialysis

Dialysis is an artificial process for removing excess water and waste from the blood. Hemodialysis and peritoneal dialysis are the types of dialysis.

The investigators followed 554 white and 262 African American dialysis patients from 81 clinics for an average of three years (range four months to 9.5 years). Among the major findings:

At five years, a lower percentage of African Americans (34%) died compared with whites (56%), as expected.
A survival advantage for African Americans only existed among patients with high levels of inflammation.
When comparing patients with lower levels of inflammation, African American and white patients survived for similar lengths of time.

What is it about inflammation that could lead to these findings? It's not clear yet, but the authors note that inflammation in whites may be caused mostly by heart disease, while in African Americans it may be due to other causes that have less detrimental effects on survival. (At the start of dialysis, half of whites in the study had heart disease compared with a third of African Americans.) Alternatively, African Americans and whites may simply respond differently to inflammation, which implies that some genetic trait allows African Americans to "handle" it better than whites.

"Our findings challenge the long held notion that African Americans do better than whites on dialysis. If we can determine, and somehow modify the impact of inflammation, we may be able to improve survival for all patients treated with dialysis," said Dr. Crews.

Source: Eurekalert

Hemodialysis Therapy Preferred by Lupus Nephritis Patients With End-stage Renal Disease

Most patients with end-stage renal disease (ESRD) caused by lupus nephritis opt hemodialysis as their initial kidney replacement therapy over peritoneal dialysis and preemptive kidney transplantation.

<< Recent Government Efforts Give a Boost to Chinese Health Co...

Breast Cancer Screening May Do More Harm Than Good >>

If Patients Don't Follow Treatments, Dialysis Clinics Are Hit

Patient characteristics affect whether dialysis clinics achieve treatment success and receive Medicare reimbursement How well kidney disease patients follow

Traditional Method of Dialysis may Not be Enough in Kidney Failure Patients

A new study published in the New England Journal of Medicine has warned that the traditional treatment method of thrice a week dialysis may not be enough